Latest news

• Regeneron’s COVID-19 antibody cocktail scores FDA emergency approval

  A COVID-19 antibody cocktail developed by Regeneron has been given an emergency use authorisation (EUA) from the US Food and Drug Administration (FDA). ... As part of that agreement, Regeneron was awarded a $450m contract by the government bodies to

• Eli Lilly’s COVID-19 antibody scores FDA emergency use approval

  Another drugmaker,   Regeneron, is also looking to obtain an EUA from the FDA for its COVID-19 antibody cocktail, REGN-COV2. ... Medical visits were reduced by 72% in patients with one or more risk factors who were receiving the investigational antibody

• Regeneron halts enrolment of severely ill patients in COVID-19 antibody trial

  Trial modified based on recommendations from independent data monitoring committee. Regeneron has announced that it has stopped enrolment of severely ill COVID-19 patients into its antibody cocktail treatment trials based ... According to Regeneron, the

• Roche and Atea link up for oral COVID-19 drug; UK to test coronavirus vaccine T cell responses

  In August, Roche also partnered with Regeneron to bolster manufacturing and global development capabilities for the latter’s investigational antibody cocktail for COVID-19.

• WHO trial casts doubt on remdesivir's efficacy

  A number of companies are developing antibodies for COVID-19, with the most notable probably being Regeneron’s antibody cocktail REGN-COV2.